Johnson & Johnson- 详细介绍、公司背景、业务范围、财务数据以及市场表现

关于 Johnson & Johnson 公司

公司简介

公司代码JNJ

公司名称Johnson & Johnson

上市日期Sep 25, 1944

成立日期1887

CEOMr. Joaquin Boix Duato

员工数量138100

证券类型Ordinary Share

年结日Sep 25

公司地址One Johnson & Johnson Plaza

城市NEW BRUNSWICK

上市交易所NYSE Consolidated

国家United States of America

邮编08933

电话17325242455

网址https://www.jnj.com/

公司代码JNJ

上市日期Sep 25, 1944

成立日期1887

公司高管

名称

名称/职务

职务

持股

持股变动

Mr. Joaquin Boix Duato

Chairman of the Board, Chief Executive Officer

407.70K

+11.95%

Ms. Jennifer L. Taubert

Executive Vice President, Worldwide Chairman, Innovative Medicine

178.01K

+14.96%

Ms. Kathryn E. Wengel

Executive Vice President, Chief Technology Officer and Risk Officer

94.62K

+14.54%

Ms. Vanessa Broadhurst

Executive Vice President - Global Corporate Affairs

23.59K

+18.96%

Mr. Joseph J. Wolk

Chief Financial Officer, Executive Vice President

16.04K

+683.59%

Prof. Dr. John C. Reed, M.D., Ph.D.

Executive Vice President - Innovative Medicine, Research and Development

15.54K

+6.62%

Ms. Kristen Mulholland

Chief Human Resource Officer

14.11K

+20.79%

Ms. Elizabeth (Liz) Forminard

Executive Vice President, General Counsel

10.90K

+30.72%

Ms. Anne M. Mulcahy

Independent Director

8.09K

+1.52%

Mr. Hubert Joly

Independent Director

5.00K

--

名称

名称/职务

职务

持股

持股变动

Mr. Joaquin Boix Duato

Chairman of the Board, Chief Executive Officer

407.70K

+11.95%

Ms. Jennifer L. Taubert

Executive Vice President, Worldwide Chairman, Innovative Medicine

178.01K

+14.96%

Ms. Kathryn E. Wengel

Executive Vice President, Chief Technology Officer and Risk Officer

94.62K

+14.54%

Ms. Vanessa Broadhurst

Executive Vice President - Global Corporate Affairs

23.59K

+18.96%

Mr. Joseph J. Wolk

Chief Financial Officer, Executive Vice President

16.04K

+683.59%

Prof. Dr. John C. Reed, M.D., Ph.D.

Executive Vice President - Innovative Medicine, Research and Development

15.54K

+6.62%

收入明细

单位: USD更新时间: 3月5日周三

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

业务USD

名称

营收

占比

Oncology-DARZALEX

11.67B

13.13%

Immunology-STELARA

10.36B

11.66%

Interventional Solutions

7.70B

8.67%

Surgery-General

5.35B

6.03%

Surgery-Advanced

4.48B

5.05%

Other

49.23B

55.43%

地区USD

名称

营收

占比

United States

50.30B

56.63%

International

38.51B

43.36%

Europe

20.21B

22.75%

Asia-Pacific, Africa

13.59B

15.30%

Western Hemisphere, excluding U.S.

4.71B

5.30%

业务

地区

业务USD

名称

营收

占比

Oncology-DARZALEX

11.67B

13.13%

Immunology-STELARA

10.36B

11.66%

Interventional Solutions

7.70B

8.67%

Surgery-General

5.35B

6.03%

Surgery-Advanced

4.48B

5.05%

Other

49.23B

55.43%

股东统计

更新时间: 2月21日周五

持股股东

股东类型

持股股东

股东统计

占比

The Vanguard Group, Inc.

9.62%

State Street Global Advisors (US)

5.58%

BlackRock Institutional Trust Company, N.A.

5.39%

Geode Capital Management, L.L.C.

2.39%

State Farm Insurance Companies

1.31%

Other

75.67%

持股股东

股东统计

占比

The Vanguard Group, Inc.

9.62%

State Street Global Advisors (US)

5.58%

BlackRock Institutional Trust Company, N.A.

5.39%

Geode Capital Management, L.L.C.

2.39%

State Farm Insurance Companies

1.31%

Other

75.67%

股东类型

股东统计

占比

Investment Advisor/Hedge Fund

33.35%

Investment Advisor

28.92%

Research Firm

2.91%

Pension Fund

2.28%

Bank and Trust

2.11%

Insurance Company

1.50%

Sovereign Wealth Fund

1.36%

Hedge Fund

0.74%

Foundation

0.43%

Other

26.35%

机构持股

更新时间: 2月20日周四

报告期

机构数

持股数

持股占比

持股变动

2025Q1

5790

1.78B

74.05%

+2.88M

2024Q4

5953

1.78B

74.14%

+8.27M

2024Q3

5699

1.76B

73.47%

+2.69M

2024Q2

5691

1.75B

72.75%

+9.12M

2024Q1

5685

1.72B

71.58%

-6.08M

2023Q4

5686

1.71B

71.40%

-7.80M

2023Q3

5524

1.71B

71.21%

-159.24M

2023Q2

5528

1.86B

71.81%

+6.27M

2023Q1

5490

1.85B

71.21%

-28.44M

2022Q4

5447

1.87B

71.55%

+6.53M

股东持股明细

名称

持股数

占比

持股变动

变动比例

公告日期

The Vanguard Group, Inc.

231.81M

9.62%

+1.80M

+0.78%

Dec 31, 2024

State Street Global Advisors (US)

134.45M

5.58%

+210.34K

+0.15%

Dec 31, 2024

BlackRock Institutional Trust Company, N.A.

130.00M

5.39%

+2.11M

+1.65%

Dec 31, 2024

Geode Capital Management, L.L.C.

57.66M

2.39%

+1.56M

+2.78%

Dec 31, 2024

State Farm Insurance Companies

31.67M

1.31%

--

Dec 31, 2024

Norges Bank Investment Management (NBIM)

30.35M

1.26%

+1.26M

+4.34%

Dec 31, 2024

Wellington Management Company, LLP

24.35M

1.01%

+431.20K

+1.80%

Dec 31, 2024

JP Morgan Asset Management

24.04M

0.99%

+5.40M

+28.99%

Dec 31, 2024

Morgan Stanley Smith Barney LLC

22.90M

0.95%

-654.87K

-2.77%

Dec 31, 2024

BlackRock Asset Management Ireland Limited

19.87M

0.82%

+587.38K

+3.04%

Dec 31, 2024

持股ETF

更新时间: 3月5日周三

机构名称

占比

iShares U.S. Pharmaceuticals ETF

23.94%

Future Fund Active ETF

13.01%

Franklin Income Focus ETF

8.56%

Federated Hermes MDT Large Cap Value ETF

7.68%

American Century Focused Large Cap Value ETF

7.36%

Health Care Select Sector SPDR Fund

7.35%

Proshares Ultra Health Care

6.65%

VanEck Pharmaceutical ETF

6.59%

iShares Core High Dividend ETF

6.57%

iShares U.S. Healthcare ETF

6.41%

iShares U.S. Pharmaceuticals ETF

占比23.94%

Future Fund Active ETF

占比13.01%

Franklin Income Focus ETF

占比8.56%

Federated Hermes MDT Large Cap Value ETF

占比7.68%

American Century Focused Large Cap Value ETF

占比7.36%

Health Care Select Sector SPDR Fund

占比7.35%

Proshares Ultra Health Care

占比6.65%

VanEck Pharmaceutical ETF

占比6.59%

iShares Core High Dividend ETF

占比6.57%

iShares U.S. Healthcare ETF

占比6.41%

分红派息

近5年累计派现 56.78B 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

Jan 02, 2025

JNJ.NB Interim Cash Dividend of gross USD 1.24 paid on Mar 04, 2025 going ex on Feb 18, 2025

Feb 18, 2025

Mar 04, 2025

Feb 18, 2025

Oct 15, 2024

JNJ.NB Final Cash Dividend of gross USD 1.24 paid on Dec 10, 2024 going ex on Nov 26, 2024

Nov 26, 2024

Dec 10, 2024

Nov 26, 2024

Jul 17, 2024

JNJ.NB Interim Cash Dividend of gross USD 1.24 paid on Sep 10, 2024 going ex on Aug 27, 2024

Aug 27, 2024

Sep 10, 2024

Aug 27, 2024

Apr 16, 2024

JNJ.NB Interim Cash Dividend of gross USD 1.24 paid on Jun 04, 2024 going ex on May 20, 2024

May 21, 2024

Jun 04, 2024

May 20, 2024

Jan 02, 2024

JNJ.NB Interim Cash Dividend of gross USD 1.19 paid on Mar 05, 2024 going ex on Feb 16, 2024

Feb 20, 2024

Mar 05, 2024

Feb 16, 2024

Oct 19, 2023

JNJ.NB Final Cash Dividend of gross USD 1.19 paid on Dec 05, 2023 going ex on Nov 20, 2023

Nov 21, 2023

Dec 05, 2023

Nov 20, 2023

Jul 20, 2023

JNJ.NB Interim Cash Dividend of gross USD 1.19 paid on Sep 07, 2023 going ex on Aug 25, 2023

Aug 28, 2023

Sep 07, 2023

Aug 25, 2023

Apr 18, 2023

JNJ.NB Interim Cash Dividend of gross USD 1.19 paid on Jun 06, 2023 going ex on May 22, 2023

May 23, 2023

Jun 06, 2023

May 22, 2023

Jan 03, 2023

JNJ.NB Interim Cash Dividend of gross USD 1.13 paid on Mar 07, 2023 going ex on Feb 17, 2023

Feb 21, 2023

Mar 07, 2023

Feb 17, 2023

Oct 18, 2022

JNJ.NB Final Cash Dividend of gross USD 1.13 paid on Dec 06, 2022 going ex on Nov 21, 2022

Nov 22, 2022

Dec 06, 2022

Nov 21, 2022

拆合股

公告日期

类型

比率

暂无数据

公告日期

类型

比率

暂无数据

Johnson & Johnson

165.120USD

Johnson & Johnson

165.120

概览

公司